Breast Cancer,Other Cancers Ribociclib vs Abemaciclib: Quality of Life in HR+/HER2- Advanced Breast Cancer May 16, 2023
Gastrointestinal Cancer,Other Cancers Phase Ib Safety and Efficacy of Cabozantinib+Durvalumab in Gastrointestinal Malignancies May 16, 2023
Genitourinary Cancer,Other Cancers KEYNOTE-426: HRQoL of Pembrolizumab+Axitinib vs Sunitinib in RCC May 16, 2023
Genitourinary Cancer,Other Cancers Latest Update on LITESPARK-022 Phase-3 Study of Belzutifan and Pembrolizumab in ccRCC May 16, 2023
Genitourinary Cancer,Other Cancers SG Efficacy in Platinum- And CPI-Refractory mUC: TROPHY-U-01 Cohort 1 Final Results May 16, 2023
Genitourinary Cancer,Other Cancers Pembrolizumab Efficacy in Platinum-Ineligible Urothelial Carcinoma May 16, 2023
Genitourinary Cancer,Other Cancers Association of imAEs With Outcomes in mUC Treated With Durvalumab With or Without Tremelimumab May 15, 2023
